NICE guideline on lipid modification
Jaques, H.
European Heart Journal 34(7): 481-482
2013
ISSN/ISBN: 0195-668X PMID: 23534074 Document Number: 667846
Document emailed within 1 workday
Related Documents
Byatt, K. 2012: NICE guideline has weaknesses Bmj 345: E5099; Author Reply E5098Taylor, C.; Richens, Y.; Shaw, F.; Evans, P. 2006: The contribution of patients and the public to the NICE guideline Rcm Midwives: the Official Journal of the Royal College of Midwives 9(10): 390-391
Hennell, S. 2009: New NICE rheumatoid arthritis guideline offers a key role for specialist nurses Nursing Times 105(10): 20
Cannon, C. 2010: The NICE Guideline on chest pain of recent onset: what does it mean for the acute physician? Acute Medicine 9(2): 98-99
Langford, N.; Stansby, G.; Avital, L. 2012: The management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE Guideline CG144 Acute Medicine 11(3): 138-142
Bourne, T. 2015: A missed opportunity for excellence: the NICE guideline on the diagnosis and initial management of ectopic pregnancy and miscarriage Journal of Family Planning and Reproductive Health Care 41(1): 13-19
Petersen, E.S.; Kelley, E.E.; Modest, E.J.; Burns, C.P. 1992: Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440 Cancer Research 52(22): 6263-6269
Schlager, S.I.; Ohanian, S.H. 1980: Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones Journal of Immunology 124(2): 626-634
Fletcher, P. 2000: Do NICE and CHI have no interest in safety? Opinion of the book NICE, CHI and the NHS reforms. Enabling excellence or imposing control? Adverse Drug Reactions and Toxicological Reviews 19(3): 167-176
Rawlins, M.D. 2001: The failings of NICE. Reply from chairman of NICE Bmj 322(7284): 489
Rose, K.D.; Ursick, J.; Maca, R. 1972: Modification of cellular lipid metabolism by psychological stress Recent Advances in Studies on Cardiac Structure and Metabolism 1: 729-741
Pourriat, J.L.; Garnier, M.; Rathat, C.; Hoang, P.; Cupa, M. 1979: Modification of erythrocyte lipids in parenteral alimentation using lipid emulsions Medecine and Chirurgie Digestives 8(2): 183-186
Hopp, H.; Leis, R.; Albus, C. 1990: Changes in carbohydrate and lipid metabolism and modification of diabetes mellitus by hormonal contraceptives Zeitschrift für Arztliche Fortbildung 84(1-2): 31-34
Lubocka, J.; Szopa, J.; Kozubek, A. 1995: Modification of the lipid component modulates nuclear matrix nucleolytic activity Acta Biochimica Polonica 42(2): 211-215
Tsukamoto, Y.; Okubo, M.; Marumo, F.; Yoneda, T.; Arai, S.; Homma, Y.; Nakamura, H. 1979: Effects of dietary modification on the lipid metabolism in patients with chronic renal failure Nihon Jinzo Gakkai Shi 21(2): 111-121
Bossmann, B.; Hütter, H.J. 1992: Modification of Memebrane Lipid composition by lipophilic agents, and its effect on the activity of membrane-bound enzymes European Journal of Clinical Chemistry and Clinical Biochemistry 30(7): 381-385
Thiengwiboonwong, S.; Chongsuwat, R.; Temcharoen, P.; Pandii, W.; Pavadhgul, P. 2013: Efficacy of dietary modification following the National Cholesterol Education Program (NCEP) recommendation on lipid profiles among hyperlipidemia subjects Journal of the Medical Association of Thailand 96(10): 1257-1267
Sanpavat, S. 2004: The use of clinical practice guideline on hyperbilirubinemia: rule or guideline Journal of the Medical Association of Thailand 87(10): 1250-1252
Kimura, M. 2011: Importance of JSLM2009 guideline and a message regarding the next set of guideline Rinsho Byori. Japanese Journal of Clinical Pathology 59(5): 482-485
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76